Michael Hahne Selected Research

Michael Hahne Research Topics

Disease

13	Rheumatoid Arthritis 01/2018 - 04/2005
8	Neoplasms (Cancer) 09/2021 - 10/2004
7	Inflammation (Inflammations) 01/2019 - 02/2011
4	Neoplasm Metastasis (Metastasis) 09/2021 - 05/2015
4	Necrosis 01/2015 - 08/2008
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 02/2013
3	Experimental Arthritis 01/2019 - 08/2014
2	Infections 01/2020 - 01/2017
2	Arthritis (Polyarthritis) 01/2019 - 08/2013
2	Osteoarthritis 01/2018 - 04/2011
2	Rheumatic Diseases (Rheumatism) 01/2018 - 04/2015
2	Breast Neoplasms (Breast Cancer) 03/2016 - 05/2015
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2013 - 09/2007
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Adenocarcinoma 01/2021
1	Colitis-Associated Neoplasms 01/2021
1	Multiple Sclerosis 01/2019
1	Contact Dermatitis (Eczema, Contact) 01/2019
1	Autoimmune Diseases of the Nervous System 01/2019
1	Atherosclerosis 01/2018
1	Colitis 01/2017
1	Ulcerative Colitis 01/2017
1	Atherosclerotic Plaque (Atheroma) 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 05/2015
1	Insulin Resistance 01/2015
1	Colonic Neoplasms (Colon Cancer) 10/2014
1	Spondylarthritis (Spinal Arthritis) 04/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2008
1	Virus Diseases (Viral Diseases) 10/2007
1	Carcinoma (Carcinomatosis) 02/2005
1	Hepatitis C 03/2004

Drug/Important Bio-Agent (IBA)

14	LigandsIBA 01/2020 - 10/2004
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2004
6	CytokinesIBA 01/2020 - 02/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2008
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 08/2014
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2008
2	Cyclin A2IBA 01/2021 - 08/2015
2	LipidsIBA 01/2018 - 01/2016
2	ABX464IBA 10/2017 - 01/2017
2	RNA (Ribonucleic Acid)IBA 10/2017 - 01/2017
2	AntibodiesIBA 01/2017 - 08/2013
2	Pharmaceutical PreparationsIBA 01/2017 - 12/2008
2	OsteoprotegerinIBA 07/2015 - 04/2011
2	Mitogen-Activated Protein KinasesIBA 05/2015 - 04/2005
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 05/2015 - 01/2015
2	B-Cell Maturation AntigenIBA 05/2015 - 08/2013
2	Cyclophilins (Cyclophilin)IBA 01/2015 - 08/2013
2	AutoantibodiesIBA 08/2014 - 08/2013
2	Biological ProductsIBA 08/2014 - 02/2013
2	B-Cell Activating FactorIBA 08/2013 - 09/2007
2	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2011 - 02/2011
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	Phospholipid Transfer ProteinsIBA 01/2018
1	Interleukin-22 (IL-22)IBA 01/2017
1	Dextran SulfateIBA 01/2017
1	Sorting NexinsIBA 03/2016
1	GTP Phosphohydrolases (GTPases)IBA 03/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Phenobarbital (Luminal)FDA Link 05/2015
1	Rituximab (Mabthera)FDA Link 04/2015
1	SteroidsIBA 04/2015
1	tocilizumab (atlizumab)FDA Link 04/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Complement Factor B (Factor B)IBA 01/2015
1	Tumor Necrosis Factor Ligand Superfamily Member 13IBA 01/2015
1	AntigensIBA 01/2015
1	CalciumIBA 01/2015
1	Fas Ligand Protein (Fas Ligand)IBA 12/2014
1	TubulinIBA 10/2014
1	Tumor Necrosis Factor InhibitorsIBA 04/2014
1	CollagenIBA 08/2013
1	TNF-Related Apoptosis-Inducing LigandIBA 08/2013
1	TACI receptor-IgG Fc fragment fusion proteinIBA 02/2013
1	Poly I-CIBA 10/2007
1	Celecoxib (Celebrex)FDA Link 01/2007
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2005
1	SerpinsIBA 02/2005
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2005
1	Antiviral Agents (Antivirals)IBA 03/2004

Therapy/Procedure

4	Therapeutics 09/2021 - 04/2014
1	Drug Therapy (Chemotherapy) 12/2008